Back

Neuroanatomical Correlates of Negative Symptoms in Schizophrenia

Kamalakannan, S. M. V.; Male, A. G.; Yilanli, M.; Lella, A.; Lee, J.; Quide, Y.; Green, M. J.; Cairns, M. J.; Carr, V. J.; Catts, S.; Henskens, F. A.; Jablensky, A.; Loughland, C.; Michie, P.; Mowry, B.; Pantelis, C.; Shall, U.; Scott, R. J.; Weickert, T. W.; Belger, A.; Bustillo, J.; Lim, K.; Ford, J. M.; Mathalon, D. H.; Preda, A.; Mueller, B.; Potkin, S. G.; Satterhwaite, T. D.; Gur, R. C.; Gur, R. E.; Banaj, N.; Vecchio, D.; Piras, F.; Piras, F.; Ehrlich, S.; Bernardoni, F.; Borgwardt, S.; Cobia, D.; Alpert, K.; Wang, L.; Agartz, I.; Jonsson, E. G.; Kaiser, S.; Pomarol-Clotet, E.; Salvador

2026-01-14 neuroscience
10.1101/2025.09.22.677864 bioRxiv
Show abstract

BackgroundSchizophrenia is characterized by widespread structural brain abnormalities, but associations between structural abnormalities and negative symptom severity are not well understood. Negative symptoms have been conceptualized in a hierarchical structure of two second-order dimensions--motivation and pleasure (MAP) and expression (EXP)--and five first-order domains: anhedonia, avolition, and asociality (MAP), and blunted affect and alogia (EXP). A better understanding of the neural circuitry underlying negative symptom dimensions and domains is important given their reported association with poor functional outcome and lack of available treatments. Study DesignThe meta-analysis included 1,591 individuals with schizophrenia across 16 samples with structural imaging and Scale for Assessment of Negative Symptoms data. The study generated correlations of cortical thickness and subcortical volumes with the negative symptom dimensions and domains. Study resultsNegative symptoms showed mainly negative associations with cortical thickness and subcortical volumes. The effect sizes were small but there was a pattern of associations in predominantly frontal lobe cortical thickness and limbic subcortical volumes. The regional correlation patterns of cortical thickness and subcortical volumes with symptom domains support the conceptualized hierarchical structure of negative symptoms: correlations of MAP domains were stronger with the MAP than EXP dimension, and vice versa. Exploratory analyses with receptor densities further supported the hierarchy. ConclusionOur findings reveal small but consistent associations between negative symptom dimensions and predominantly prefrontal region cortical thickness, and limbic region volumes. These findings advance our understanding of the network of anatomical regions that may contribute to the severity of negative symptoms in schizophrenia.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Schizophrenia Research
29 papers in training set
Top 0.1%
21.9%
2
Schizophrenia Bulletin
29 papers in training set
Top 0.1%
12.1%
3
Biological Psychiatry
119 papers in training set
Top 0.4%
8.2%
4
Psychological Medicine
74 papers in training set
Top 0.3%
6.2%
5
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
62 papers in training set
Top 0.3%
4.7%
50% of probability mass above
6
Translational Psychiatry
219 papers in training set
Top 1%
4.7%
7
NeuroImage: Clinical
132 papers in training set
Top 1%
3.5%
8
Schizophrenia
19 papers in training set
Top 0.1%
3.5%
9
Progress in Neuro-Psychopharmacology and Biological Psychiatry
36 papers in training set
Top 0.2%
3.5%
10
Frontiers in Psychiatry
83 papers in training set
Top 1%
2.7%
11
Brain Imaging and Behavior
14 papers in training set
Top 0.1%
2.7%
12
Molecular Psychiatry
242 papers in training set
Top 1%
2.5%
13
PLOS ONE
4510 papers in training set
Top 49%
2.0%
14
Psychiatry Research: Neuroimaging
16 papers in training set
Top 0.1%
2.0%
15
Human Brain Mapping
295 papers in training set
Top 3%
1.8%
16
Neuropsychopharmacology
134 papers in training set
Top 2%
1.6%
17
Scientific Reports
3102 papers in training set
Top 72%
0.9%
18
JAMA Psychiatry
13 papers in training set
Top 0.5%
0.8%
19
Neuroscience & Biobehavioral Reviews
43 papers in training set
Top 1%
0.7%
20
Journal of Psychopharmacology
14 papers in training set
Top 0.6%
0.7%
21
Psychiatry and Clinical Neurosciences
11 papers in training set
Top 0.4%
0.7%
22
Psychiatry Research
35 papers in training set
Top 2%
0.6%
23
Brain, Behavior, and Immunity
105 papers in training set
Top 3%
0.6%
24
The British Journal of Psychiatry
21 papers in training set
Top 1%
0.6%
25
Frontiers in Neuroimaging
11 papers in training set
Top 0.5%
0.6%